Overview
Aehr Test Systems reports fiscal Q4 net revenue of $14.1 mln, missing expectations, per LSEG data
Co expands into AI processors and gallium nitride (GaN) semiconductors for future growth
Maintains "cautious approach" due to tariff-related uncertainty
Outlook
Co anticipates order growth across all segments with possible exception of silicon carbide
Aehr Test Systems maintains cautious approach due to tariff-related uncertainty, per President and CEO Gayn Erickson
Company sees significant growth opportunities in AI and GaN markets
Aehr Test Systems not reinstating specific guidance beyond stated expectations
Result Drivers
AI PROCESSORS EXPANSION - Co launched first production wafer level burn-in system for AI processors, attracting interest from leading processor companies
GAN SEMICONDUCTORS - Secured first production order for GaN devices, highlighting growing adoption and future opportunities
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Sales | Miss | $14.09 mln | $14.80 mln (2 Analysts) |
Q4 Adjusted Net Income | Beat | -$248,000 | -$417,000 (2 Analysts) |
Q4 Net Income |
| -$2.90 mln |
|
Q4 Adjusted Income from Operations | Miss | -$553,000 | -$56,000 (1 Analyst) |
Q4 Adjusted Pretax Profit |
| -$335,000 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the semiconductor equipment & testing peer group is "buy"
Wall Street's median 12-month price target for Aehr Test Systems is $12.75, about 16.2% below its July 7 closing price of $14.82
The stock recently traded at 80 times the next 12-month earnings vs. a P/E of 19 three months ago
Press Release: ID:nACS5L5pZa